# KLHL33

## Overview
KLHL33 is a gene that encodes the protein kelch-like family member 33, which is part of the kelch-like (KLHL) protein family. These proteins are characterized by the presence of kelch motifs, which are involved in protein-protein interactions and are often associated with ubiquitination processes (Shi2019Kelchlike). The KLHL33 protein is implicated in various cellular functions, although its precise biological roles remain to be fully elucidated. Recent studies have highlighted its potential involvement in cancer biology, particularly in colon cancer, where its expression levels correlate with patient prognosis (Xiang2021Targeting). As a member of the KLHL family, KLHL33 may contribute to the regulation of cellular processes through its interactions with other proteins, suggesting its potential as a therapeutic target in oncology (Xiang2021Targeting).

## Clinical Significance
KLHL33 has been identified as having clinical significance in the context of cancer. High expression levels of KLHL33 are associated with a poorer prognosis in colon cancer, suggesting its potential role as a biomarker for this disease. This association was determined through analyses using databases such as GEPIA and Kaplan-Meier Plotter, which evaluate mRNA expression levels and patient survival data (Xiang2021Targeting). The study highlights that KLHL33, along with other KLHL proteins, could serve as a potential drug target in cancer therapy due to its significant clinical score derived from expression and prognosis data (Xiang2021Targeting).

While KLHL33 was identified as having a potential role in promoting cancer cell proliferation, it was not the primary focus of subsequent validation studies that targeted other KLHL proteins using lentiviral shRNA (Xiang2021Targeting). This suggests that while KLHL33 may contribute to cancer progression, its specific mechanisms and interactions in cancer cells require further investigation. The broader role of KLHL proteins in diseases, including their involvement in ubiquitination processes, underscores the importance of understanding KLHL33's interactions and expression patterns in pathological conditions (Shi2019Kelchlike).


## References


[1. (Shi2019Kelchlike) Xiaoxian Shi, Senfeng Xiang, Ji Cao, Hong Zhu, Bo Yang, Qiaojun He, and Meidan Ying. Kelch-like proteins: physiological functions and relationships with diseases. Pharmacological Research, 148:104404, October 2019. URL: http://dx.doi.org/10.1016/j.phrs.2019.104404, doi:10.1016/j.phrs.2019.104404. This article has 51 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.phrs.2019.104404)

[2. (Xiang2021Targeting) Senfeng Xiang, Xiaoxian Shi, Pengfei Chen, Yifan Chen, Shaowei Bing, Xizhi Jin, Ji Cao, Jinhu Wang, Bo Yang, Xuejing Shao, Qiaojun He, and Meidan Ying. Targeting cul3-scaffold e3 ligase complex via klhl substrate adaptors for cancer therapy. Pharmacological Research, 169:105616, July 2021. URL: http://dx.doi.org/10.1016/j.phrs.2021.105616, doi:10.1016/j.phrs.2021.105616. This article has 10 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.phrs.2021.105616)